Product Information
QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.1465 per EA under NDC 16729014912. Its NADAC has been published 652 times since Nov 28, 2013.
FDA first approved this application on Mar 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729014912
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA202152FDA Approved
3/27/2012
TE Code
AB
On Market Since
3/28/2012
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 652 times since Nov 28, 2013, and over the history we have for it it has declined 67.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1465 per EA |
|---|---|
| All-time high | $0.4855 (Feb 12, 2014) |
| All-time low | $0.1136 (Nov 20, 2024) |
| 52-week high | $0.1465 |
| 52-week low | $0.1265 |
| Median price | $0.1834 |
| Average price | $0.2266 |
| Largest weekly change | -26.7% (Nov 20, 2024) |
| Weeks tracked | 652 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+14.2%
1Y
+1.1%
3Y
+13.5%
5Y
-8.9%
All
-67.8%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by Accord Healthcare Inc., is $0.1465 per EA (NDC 16729014912), effective May 20, 2026.
How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?
Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 67.8%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?
Since Nov 28, 2013, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1136 (Nov 20, 2024) to a high of $0.4855 (Feb 12, 2014), with a median of $0.1834 per EA.
Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1285 per EA — about 12% below QUETIAPINE FUMARATE 300 MG TAB.
Who manufactures QUETIAPINE FUMARATE 300 MG TAB?
QUETIAPINE FUMARATE 300 MG TAB (NDC 16729014912) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.